Active, not recruitingPhase 4NCT05180526

Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bio-Thera Solutions
Principal Investigator
Peizeng Yang, M.D
1 Youyi Road, Yuzhong District, Chongqing, China
Intervention
QLETLI(drug)
Enrollment
60 target
Eligibility
18-70 years · All sexes
Timeline
20212024

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05180526 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials